{
  "trial_id": "NCT02680574",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, race, baseline hemoglobin levels, estimated glomerular filtration rate (eGFR), serum ferritin levels, transferrin saturation (TSAT), current erythropoiesis-stimulating agents (ESA) therapy dose, history of hypertension, history of heart failure, history of acute coronary syndrome, history of stroke, hypersensitivity to study drugs.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Average hemoglobin",
          "baseline hemoglobin levels"
        ],
        [
          "Mean estimated glomerular filtration rate",
          "estimated glomerular filtration rate (eGFR)"
        ],
        [
          "Number of Participants with NYHA Functional Classification of Heart Failure",
          "history of heart failure"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Number of Participants with History of Diabetes",
        "Number of Participants with Any History of Heart Failure"
      ],
      "remaining_candidate_features": [
        "serum ferritin levels",
        "transferrin saturation (TSAT)",
        "current erythropoiesis-stimulating agents (ESA) therapy dose",
        "history of hypertension",
        "history of acute coronary syndrome",
        "history of stroke",
        "hypersensitivity to study drugs."
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline Hemoglobin, Serum Ferritin, Transferrin Saturation (TSAT), Estimated Glomerular Filtration Rate (eGFR), Blood Pressure, History of Cardiovascular Disease, Duration of Chronic Kidney Disease,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Average hemoglobin",
          "Baseline Hemoglobin"
        ],
        [
          "Mean estimated glomerular filtration rate",
          "Estimated Glomerular Filtration Rate (eGFR)"
        ],
        [
          "Number of Participants with NYHA Functional Classification of Heart Failure",
          "History of Cardiovascular Disease"
        ]
      ],
      "remaining_reference_features": [
        "Number of Participants with History of Diabetes",
        "Number of Participants with Any History of Heart Failure"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Serum Ferritin",
        "Transferrin Saturation (TSAT)",
        "Blood Pressure",
        "Duration of Chronic Kidney Disease"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Estimated Glomerular Filtration Rate, Hemoglobin, Serum Ferritin, Transferrin Saturation, Systolic Blood Pressure, Diastolic Blood Pressure, History of Cardiovascular Disease, History of Heart Failure, History of Stroke.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Mean estimated glomerular filtration rate",
          "Estimated Glomerular Filtration Rate"
        ],
        [
          "Average hemoglobin",
          "Hemoglobin"
        ],
        [
          "Number of Participants with NYHA Functional Classification of Heart Failure",
          "History of Heart Failure"
        ]
      ],
      "remaining_reference_features": [
        "Number of Participants with History of Diabetes",
        "Number of Participants with Any History of Heart Failure"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "Serum Ferritin",
        "Transferrin Saturation",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "History of Cardiovascular Disease",
        "History of Stroke."
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), estimated glomerular filtration rate (eGFR), hemoglobin level, serum ferritin level, transferrin saturation (TSAT), erythropoiesis-stimulating agents (ESA) dose, comorbidities (e.g., hypertension, heart failure, coronary artery disease), New York Heart Association (NYHA) class, history of cardiovascular events (e.g., myocardial infarction, stroke), smoking status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Average hemoglobin",
          "hemoglobin level"
        ],
        [
          "Mean estimated glomerular filtration rate",
          "estimated glomerular filtration rate (eGFR)"
        ],
        [
          "Number of Participants with NYHA Functional Classification of Heart Failure",
          "New York Heart Association (NYHA) class"
        ],
        [
          "Number of Participants with Any History of Heart Failure",
          "comorbidities (e.g., hypertension, heart failure, coronary artery disease)"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Number of Participants with History of Diabetes"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "serum ferritin level",
        "transferrin saturation (TSAT)",
        "erythropoiesis-stimulating agents (ESA) dose",
        "history of cardiovascular events (e.g., myocardial infarction, stroke)",
        "smoking status"
      ]
    }
  }
}